Loading clinical trials...
Loading clinical trials...
This study is a multi-center, prospective, single-arm, non-significant risk (NSR) device study in which up to 150 evaluable subjects with suspicion of embolic stroke of undetermined source (ESUS) will...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NovaSignal Corp.
NCT07414732 · Stroke, Intracerebral Haemorrhage, and more
NCT06783049 · Ischemic Stroke, Transient Ischemic Attack (TIA)
NCT07319312 · Stroke Acute, Stroke (CVA) or Transient Ischemic Attack
NCT07143149 · Ischemic Stroke, Transient Ischemic Attack (TIA)
NCT07113041 · Stroke, Stroke (CVA) or Transient Ischemic Attack, and more
Barrow Neurological Institute
Phoenix, Arizona
Providence Brain & Spine Institute
Portland, Oregon
Providence St. Vincent Medical Center
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions